Differential Expression of Kv1.3 and Kv1.5 Voltage-Dependent K⁺ Channels in Human Skeletal Muscle Sarcomas

REFERENCES

• Hille B. Ion Channels of Excitable Membranes, 3rd edition. Sunderland, MA: Sinauer, 2001;xviii:814.
   Google Scholar
• Conti M. Targeting K+ channels for cancer therapy. J Exp Ther Oncol 2004;4:161–166.
   PubMedGoogle Scholar
• Felipe A, Vicente R, Villalonga N, Roura-Ferrer M, Martinez-Marmol R, Sole L, Ferreres JC, Condom, E. Potassium channels: new targets in cancer therapy. Cancer Detect Prev 2006;30:375–385.
   PubMedGoogle Scholar
• Kunzelmann K. Ion channels and cancer. J Membr Biol 2005;205:159–173.
   PubMed Web of Science ®Google Scholar
• Pardo LA. Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 2004;19:285–292.
   PubMed Web of Science ®Google Scholar
• Wonderlin WF, Strobl JS. Potassium channels, proliferation and G1 progression. J Membr Biol 1996;154:91–107.
   PubMed Web of Science ®Google Scholar
• Vicente R, Escalada A, Villalonga N, Texido L, Roura-Ferrer M, Martin-Satue M, Lopez-Iglesias C, Soler C, Solsona C, Tamkun MM, Felipe A. Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. J Biol Chem 2006;281:37675–37685.
   PubMed Web of Science ®Google Scholar
• Villalonga N, Martinez-Marmol R, Roura-Ferrer M, David M, Valenzuela C, Soler C, Felipe A. Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation. Biochim Biophys Acta 2008;1783:728–736.
   PubMed Web of Science ®Google Scholar
• Swanson R, Marshall J, Jeffrey S, Smith JS, Williams JB, Boyle MB, Folander K, Luneau CJ, Antanavage J, Oliva C, Buhrow SA, Bennet C, Stein RB, Kaczmarek LK. Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brain. Neuron 1990;4:929–939.
   PubMed Web of Science ®Google Scholar
• Bielanska J, Hernandez-Losa J, Perez-Verdaguer M, Moline T, Somoza R, Ramon YCS, Condom E, Ferreres JC, Felipe A. Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer. Curr Cancer Drug Targets 2009;9:904–914.
   PubMed Web of Science ®Google Scholar
• Cheong A, Li J, Sukumar P, Kumar B, Zeng F, Riches K, Munsch C, Wood IC, Porter KE, Beech DJ. Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers. Cardiovasc Res 2011;89:282– 289.
   PubMed Web of Science ®Google Scholar
• Cidad P, Moreno-Dominguez A, Novensa L, Roque M, Barquin L, Heras M, Perez-Garcia MT, Lopez-Lopez JR. Characterization of ion channels involved in the proliferative response of femoral artery smooth muscle cells. Arterioscler Thromb Vasc Biol 2010;30:1203–1211.
   PubMed Web of Science ®Google Scholar
• Vicente R, Escalada A, Coma M, Fuster G, Sanchez-Tillo E, Lopez-Iglesias C, Soler C, Solsona C, Celada A, Felipe A. Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages. J Biol Chem 2003;278:46307–46320.
   PubMed Web of Science ®Google Scholar
• Villalonga N, Escalada A, Vicente R, Sanchez-Tillo E, Celada A, Solsona C, Felipe A. Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages. Biochem Biophys Res Commun 2007;352:913–918.
   PubMed Web of Science ®Google Scholar
• Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 1999;341:342–352.
   PubMed Web of Science ®Google Scholar
• Qualman SJ, Coffin CM, Newton WA, Hojo H, Triche TJ, Parham DM, Crist WM. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol 1998;1:550–561.
   PubMed Web of Science ®Google Scholar
• Bielanska J, Hernandez-Losa J, Moline T, Somoza R, Ramon YCS, Condom E, Ferreres JC, Felipe A. Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human fetus. Cell Physiol Biochem 2010;26:219–226.
   PubMed Web of Science ®Google Scholar
• Lan M, Shi Y, Han Z, Hao Z, Pan Y, Liu N, Guo C, Hong L, Wang J, Qiao T, Fan D. Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells. Cancer Biol Ther 2005;4:1342–1347.
   PubMed Web of Science ®Google Scholar
• Castellvi J, Garcia A, Ruiz-Marcellan C, Hernandez-Losa J, Peg V, Salcedo M, Gil-Moreno A, Ramon y Cajal S. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis. Hum Pathol 2009;40:1418–1426.
   PubMed Web of Science ®Google Scholar
• Felipe A, Snyders DJ, Deal KK, Tamkun MM. Influence of cloned voltage-gated K+ channel expression on alanine transport, Rb+ uptake, and cell volume. Am J Physiol 1993;265:C1230–C1238.
   PubMed Web of Science ®Google Scholar
• Davies AM, Batchelor TJ, Eardley I, Beech DJ. Potassium channel KV alpha1 subunit expression and function in human detrusor muscle. J Urol 2002;167:1881–1886.
   PubMed Web of Science ®Google Scholar
• Xu J, Wang P, Li Y, Li G, Kaczmarek LK, Wu Y, Koni PA, Flavell RA, Desir GV. The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity. Proc Natl Acad Sci USA 2004;101:3112–3117.
   PubMed Web of Science ®Google Scholar
• Ravitz MJ, Wenner CE. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta. Adv Cancer Res 1997;71:165–207.
   PubMed Web of Science ®Google Scholar
• Juuti A, Nordling S, Louhimo J, Lundin J, von Boguslawski K, Haglund C. Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer. Oncology 2003;65:371– 377.
   PubMed Web of Science ®Google Scholar
• Khan AA, Abel PD, Chaudhary KS, Gulzar Z, Stamp GW, Lalani EN. Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder. Mol Pathol 2003;56:353–361.
   PubMedGoogle Scholar
• Miyachi M, Kakazu N, Yagyu S, Katsumi Y, Tsubai-Shimizu S, Kikuchi K, Tsuchiya K, Iehara T, Hosoi H. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells. Clin Cancer Res 2009;15:4077–4084.
   PubMed Web of Science ®Google Scholar
• Pateras IS, Apostolopoulou K, Niforou K, Kotsinas A, Gorgoulis VG. p57KIP2: “Kip”ing the cell under control. Mol Cancer Res 2009;7:1902–1919.
   PubMed Web of Science ®Google Scholar
• Renaudo A, Watry V, Chassot AA, Ponzio G, Ehrenfeld J, Soriani O. Inhibition of tumor cell proliferation by sigma ligands is associated with K+ Channel inhibition and p27kip1 accumulation. J Pharmacol Exp Ther 2004;311:1105–1114.
   PubMed Web of Science ®Google Scholar